Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers urge healthcare systems to develop ways to support people recovering from COVID-19

Healthcare systems around the world need to develop ways of supporting people in the community who are recovering from COVID-19, say researchers.

27 Aug 2020

UKRI funding could initiate clinical trial for Cambridge-developed DNA vaccine against SARS-CoV-2

A Cambridge-developed DNA vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9 million award from the UK government.

27 Aug 2020

Obesity ups COVID-19 death risk by 48 percent

Now, a new study by researchers from the University of North Carolina (UNC), the World Bank, and Saudi Health Council, shows that obesity increases the risk of dying from COVID-19 by as much as 48 percent, hinting that a vaccine against the virus could be less effective in obese people.

26 Aug 2020

Study reveals a troubling connection between coronavirus and obesity

A review of COVID-19 studies reveals a troubling connection between two health crises: coronavirus and obesity.

26 Aug 2020

Time-saving automation for small biobanks

Ziath reports strong uptake of its Mohawk semi-automated tube picker in smaller biobanks and biorepositories.

From Ziath Ltd 26 Aug 2020

Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro

A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.

26 Aug 2020

Identifying COVID-19 host genes using symptom-based predictions

A recent study published on the preprint server bioRxiv* in August 2020 shows that symptom-based prediction of the diagnosis can help identify host genes that are responsible for part of this variability.

26 Aug 2020

UC Berkeley demographers calculate the consequences of U.S. lives lost to COVID-19

With over 170,000 COVID-19 deaths to date, and 1,000 more each day, America's life expectancy may appear to be plummeting.

25 Aug 2020

Monoclonal antibodies may be a better choice than convalescent plasma for treating COVID-19

A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.

25 Aug 2020

Preclinical studies of a COVID-19 vaccine candidate show positive results

Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive results that appear to distinguish this vaccine candidate from other vaccine candidates that are currently in advanced stages of clinical development, the Maryland-based Altimmune Inc. announced today.

25 Aug 2020

High SARS-CoV-2 antibody seroprevalence, low mortality at Austrian COVID-19 epicenter

Now, a new study reported on the preprint server medRxiv* in August 2020 describes a high seroprevalence in an Austrian ski resort, which is considered to be the source of the European outbreak.

25 Aug 2020

UVA-designed nasopharyngeal swabs to support high-priority COVID-19 testing across Virginia

The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.

25 Aug 2020

Allowing low-level CMV infection may boost immunity in stem cell transplant recipients

Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team of cellular-therapy specialists from Roswell Park Comprehensive Cancer Center has found.

25 Aug 2020

Advances in Virus Epigenetics

Growing evidence shows viruses exploit epigenetic processes to control their life cycles but epigentic regulation of viral infections is not fully understood.

From Chromatrap® - Porvair Sciences Ltd 25 Aug 2020

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.

25 Aug 2020

Online searches for 'heart attack' drop during COVID-19, but rise for 'chest pain'

A study of search engine queries addressed the question of whether online searches for chest pain symptoms correlated to reports of fewer people going to the emergency department with acute heart problems during the COVID-19 pandemic.

25 Aug 2020

New approach involves "antivitamins" to develop new classes of antibiotics

Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

25 Aug 2020

Health experts provide guidelines on scientific investigation of synbiotics

Chances are you've heard of or even taken probiotics: supplements delivering "good microbes" to the gut, providing a wide range of health benefits. If you're really up on your gut health, you may also be aware of prebiotics: supplements designed to fuel the good microbes already living in our guts.

25 Aug 2020

World's first confirmed case of SARS-CoV-2 re-infection

A team of researchers at the University of Hong Kong said that they have proven that a 33-year-old man was infected by the SARS-CoV-2 virus for a second time. The man was discharged from a hospital in April but contracted the infection again after returning from Spain via the United Kingdom in August.

24 Aug 2020

Relative humidity could play a role in transmission of SARS-CoV-2 indoors

A new study has explored the role of relative humidity in the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from person to person indoors. The study titled, “An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments,” is published in the latest issue of the journal Aerosol and Air Quality Research.

24 Aug 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Researchers urge healthcare systems to develop ways to support people recovering from COVID-19

UKRI funding could initiate clinical trial for Cambridge-developed DNA vaccine against SARS-CoV-2

Obesity ups COVID-19 death risk by 48 percent

Study reveals a troubling connection between coronavirus and obesity

Time-saving automation for small biobanks

Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro

Identifying COVID-19 host genes using symptom-based predictions

UC Berkeley demographers calculate the consequences of U.S. lives lost to COVID-19

Monoclonal antibodies may be a better choice than convalescent plasma for treating COVID-19

Preclinical studies of a COVID-19 vaccine candidate show positive results

High SARS-CoV-2 antibody seroprevalence, low mortality at Austrian COVID-19 epicenter

UVA-designed nasopharyngeal swabs to support high-priority COVID-19 testing across Virginia

Allowing low-level CMV infection may boost immunity in stem cell transplant recipients

Advances in Virus Epigenetics

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

Online searches for 'heart attack' drop during COVID-19, but rise for 'chest pain'

New approach involves "antivitamins" to develop new classes of antibiotics

Health experts provide guidelines on scientific investigation of synbiotics

World's first confirmed case of SARS-CoV-2 re-infection

Relative humidity could play a role in transmission of SARS-CoV-2 indoors

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in